Skip to content

Emergent Biosolutions EBS Proceeds from disposals of property, plant and equipment

Proceeds from disposals of property, plant and equipment at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
Opko Health logo
Opko HealthOPK
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's proceeds from disposals of property, plant and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's proceeds from disposals of property, plant and equipment?
Emergent Biosolutions (EBS) reported proceeds from disposals of property, plant and equipment of $0 in Q1 2026.
How has Emergent Biosolutions's proceeds from disposals of property, plant and equipment changed year-over-year?
Emergent Biosolutions's proceeds from disposals of property, plant and equipment decreased by 100.0% year-over-year, from $38.1M to $0.